Promyelocytic Leukemia (PML) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 2000 Jan 29

PMID 10648561

Citations 114

Authors

F M Boisvert

M J Hendzel

D P Bazett-Jones

Affiliations

Soon will be listed here.

Abstract

The promyelocytic leukemia (PML) nuclear body (also referred to as ND10, POD, and Kr body) is involved in oncogenesis and viral infection. This subnuclear domain has been reported to be rich in RNA and a site of nascent RNA synthesis, implicating its direct involvement in the regulation of gene expression. We used an analytical transmission electron microscopic method to determine the structure and composition of PML nuclear bodies and the surrounding nucleoplasm. Electron spectroscopic imaging (ESI) demonstrates that the core of the PML nuclear body is a dense, protein-based structure, 250 nm in diameter, which does not contain detectable nucleic acid. Although PML nuclear bodies contain neither chromatin nor nascent RNA, newly synthesized RNA is associated with the periphery of the PML nuclear body, and is found within the chromatin-depleted region of the nucleoplasm immediately surrounding the core of the PML nuclear body. We further show that the RNA does not accumulate in the protein core of the structure. Our results dismiss the hypothesis that the PML nuclear body is a site of transcription, but support the model in which the PML nuclear body may contribute to the formation of a favorable nuclear environment for the expression of specific genes.

Citing Articles

Biomolecular condensates in immune cell fate.

Kodali S, Sands C, Guo L, Huang Y, Di Stefano B Nat Rev Immunol. 2025; .

PMID: 39875604 DOI: 10.1038/s41577-025-01130-z.

History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies.

Bercier P, de The H Cancers (Basel). 2024; 16(7).

PMID: 38611029 PMC: 11011038. DOI: 10.3390/cancers16071351.

On the Prevalence and Roles of Proteins Undergoing Liquid-Liquid Phase Separation in the Biogenesis of PML-Bodies.

Silonov S, Mokin Y, Nedelyaev E, Smirnov E, Kuznetsova I, Turoverov K Biomolecules. 2023; 13(12).

PMID: 38136675 PMC: 10741438. DOI: 10.3390/biom13121805.

PML modulates epigenetic composition of chromatin to regulate expression of pro-metastatic genes in triple-negative breast cancer.

Fracassi C, Ugge M, Abdelhalim M, Zapparoli E, Simoni M, Magliulo D Nucleic Acids Res. 2023; 51(20):11024-11039.

PMID: 37823593 PMC: 10639071. DOI: 10.1093/nar/gkad819.

Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns.

Perez-Berlanga M, Wiersma V, Zbinden A, De Vos L, Wagner U, Foglieni C EMBO J. 2023; 42(17):e111719.

PMID: 37431963 PMC: 10476175. DOI: 10.15252/embj.2022111719.

References

Desbois C, Rousset R, Bantignies F, Jalinot P . Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science. 1996; 273(5277):951-3. DOI: 10.1126/science.273.5277.951. View

Grotzinger T, Sternsdorf T, Jensen K, Will H . Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem. 1996; 238(2):554-60. DOI: 10.1111/j.1432-1033.1996.0554z.x. View

Grande M, van der Kraan I, van Steensel B, Schul W, de The H, van der Voort H . PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J Cell Biochem. 1996; 63(3):280-91. DOI: 10.1002/(sici)1097-4644(19961201)63:3<280::aid-jcb3>3.0.co;2-t. View

Boggs B, Connors B, Sobel R, Chinault A, Allis C . Reduced levels of histone H3 acetylation on the inactive X chromosome in human females. Chromosoma. 1996; 105(5):303-9. DOI: 10.1007/BF02524648. View

Ishov A, Stenberg R, Maul G . Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol. 1997; 138(1):5-16. PMC: 2139949. DOI: 10.1083/jcb.138.1.5. View

Sternsdorf T, Jensen K, Will H . Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol. 1998; 139(7):1621-34. PMC: 2132645. DOI: 10.1083/jcb.139.7.1621. View

Muller S, Matunis M, Dejean A . Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 1998; 17(1):61-70. PMC: 1170358. DOI: 10.1093/emboj/17.1.61. View

Vallian S, Gaken J, Trayner I, Gingold E, Kouzarides T, Chang K . Transcriptional repression by the promyelocytic leukemia protein, PML. Exp Cell Res. 1998; 237(2):371-82. DOI: 10.1006/excr.1997.3801. View

Hendzel M, Boisvert F, Bazett-Jones D . Direct visualization of a protein nuclear architecture. Mol Biol Cell. 1999; 10(6):2051-62. PMC: 25413. DOI: 10.1091/mbc.10.6.2051. View

10.

Bazett-Jones D, Hendzel M, Kruhlak M . Stoichiometric analysis of protein- and nucleic acid-based structures in the cell nucleus. Micron. 1999; 30(2):151-7. DOI: 10.1016/s0968-4328(99)00019-0. View

11.

Chen T, Boisvert F, Bazett-Jones D, Richard S . A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines. Mol Biol Cell. 1999; 10(9):3015-33. PMC: 25546. DOI: 10.1091/mbc.10.9.3015. View

12.

Bernhard W . A new staining procedure for electron microscopical cytology. J Ultrastruct Res. 1969; 27(3):250-65. DOI: 10.1016/s0022-5320(69)80016-x. View

13.

de The H, Chomienne C, Lanotte M, Degos L, Dejean A . The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature. 1990; 347(6293):558-61. DOI: 10.1038/347558a0. View

14.

Borrow J, Goddard A, Sheer D, Solomon E . Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science. 1990; 249(4976):1577-80. DOI: 10.1126/science.2218500. View

15.

Szostecki C, Guldner H, Netter H, Will H . Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol. 1990; 145(12):4338-47. View

16.

Ascoli C, Maul G . Identification of a novel nuclear domain. J Cell Biol. 1991; 112(5):785-95. PMC: 2288866. DOI: 10.1083/jcb.112.5.785. View

17.

Kakizuka A, Miller Jr W, Umesono K, Warrell Jr R, Frankel S, Murty V . Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell. 1991; 66(4):663-74. DOI: 10.1016/0092-8674(91)90112-c. View

18.

de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A . The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 1991; 66(4):675-84. DOI: 10.1016/0092-8674(91)90113-d. View

19.

Stuurman N, de Graaf A, Floore A, Josso A, Humbel B, de Jong L . A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci. 1992; 101 ( Pt 4):773-84. DOI: 10.1242/jcs.101.4.773. View

20.

de Graaf A, Humbel B, Stuurman N, van Bergen en Henegouwen P, Verkleij A . Three-dimensional immunogold labeling of nuclear matrix proteins in permeabilized cells. Cell Biol Int Rep. 1992; 16(8):827-36. DOI: 10.1016/s0309-1651(05)80025-6. View